$TPH

Tri Pointe Homes, Inc.

No enriched coverage for $TPH in the last 7 days.

No SEC Form 4 filings for $TPH in the last 30 days.

Med

Pacer Advisors Inc. Sells 190,083 Shares of Tri Pointe Homes Inc. $TPH

Pacer Advisors Inc. significantly reduced its stake in Tri Pointe Homes Inc. by selling 190,083 shares, bringing their total ownership to 315,218 shares valued at $9.92 million. Despite some analysts raising price targets, the consensus rating for Tri Pointe Homes remains "Hold" with an average price target of $42.50. The company recently missed earnings estimates, reporting an EPS of $0.08 against an expected $0.30, although revenue slightly exceeded forecasts.

Tri Pointe Homes (TPH) Margin Compression Challenges Bullish Narratives Heading Into Q1 2026 Earnings

Tri Pointe Homes (TPH) is facing significant margin compression, with net profit falling from 10.2% to 6.9% year-over-year and trailing earnings declining at an annualized 5.3% over five years. This contrasts with optimistic narratives around premium homes and strong liquidity. Analysts anticipate further margin decline, and the stock's current valuation of 16.5x P/E is above the industry average, suggesting it may be overvalued given the declining profitability.

Tri Pointe Homes (TPH) Releases Q1 2026 Earnings: Revenue Down 29.8%, EPS $0.08

Tri Pointe Homes (TPH) reported a significant decline in its first-quarter 2026 earnings, with total revenue decreasing by 29.8% year-over-year to $507.9 million and diluted EPS falling by 88.6% to $0.08. The company experienced steep drops in gross profit, operating profit, and net income, despite maintaining a substantial cash balance. The report also details insider trading activity, hedge fund movements, Congressional stock trading, and analyst price targets for TPH.

News on $TPH